1.
Discovery, Biosynthesis, and Engineering of Lantipeptides
by Knerr, Patrick J
Annual review of biochemistry, 2012, Vol.81 (1), p.479-505
2.
Lantibiotics: structure, biosynthesis and mode of action
by McAuliffe, Olivia
FEMS microbiology reviews, 2001, Vol.25 (3), p.285-308
3.
Bacillus velezensis RC 218 as a biocontrol agent to reduce Fusarium head blight and deoxynivalenol accumulation: Genome sequencing and secondary metabolite cluster profiles
by Palazzini, Juan M
Microbiological research, 2016, Vol.192, p.30-36
4.
Diversity and applications of Bacillus bacteriocins
by Abriouel, Hikmate
FEMS microbiology reviews, 2011, Vol.35 (1), p.201-232
5.
Identification of a novel two-peptide lantibiotic, Haloduracin, produced by the alkaliphile Bacillus halodurans C-125
by Lawton, Elaine M
FEMS microbiology letters, 2007, Vol.267 (1), p.64-71
6.
Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development
by Eckert, Randal
Future microbiology, 2011, Vol.6 (6), p.635-651
7.
Lantibiotics: Promising candidates for future applications in health care
by Dischinger, Jasmin
International journal of medical microbiology, 2013, Vol.304 (1), p.51-62
8.
The biology of lantibiotics from the lacticin 481 group is coming of age
by Dufour, Alain
FEMS microbiology reviews, 2007, Vol.31 (2), p.134-167
9.
Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials
by Montalbán-López, Manuel
FEMS microbiology reviews, 2017, Vol.41 (1), p.5-18
10.
Lantibiotics: structure, biosynthesis and mode of action
by McAuliffe, Olivia
FEMS microbiology reviews, 2001, Vol.25 (3), p.285-308
11.
Developing oral probiotics from Streptococcus salivarius
by Wescombe, Philip A
Future microbiology, 2012, Vol.7 (12), p.1355-1371
12.
High-throughput sequence-based analysis of the bacterial composition of kefir and an associated kefir grain
by Dobson, Alleson
FEMS microbiology letters, 2011, Vol.320 (1), p.56-62
13.
Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics
by Wescombe, Philip A
Future microbiology, 2009, Vol.4 (7), p.819-835
14.
Biosynthesis of paenibacillin, a lantibiotic with N-terminal acetylation, by Paenibacillus polymyxa
by Huang, En
Microbiological research, 2015, Vol.181, p.15-21
15.
Bacteriocins: mechanism of membrane insertion and pore formation
by Moll, G.N
Antonie van Leeuwenhoek, 1999, Vol.76 (1), p.185-198
16.
An oldie but a goodie – cell wall biosynthesis as antibiotic target pathway
by Schneider, Tanja
International journal of medical microbiology, 2009, Vol.300 (2), p.161-169
17.
The expanding role of lipid II as a target for lantibiotics
by Martin, Nathaniel I
Future microbiology, 2007, Vol.2 (5), p.513-525
18.
Mutagenesis of nisin’s leader peptide proline strongly modulates export of precursor nisin
by Plat, Annechien
Antonie van Leeuwenhoek, 2016, Vol.110 (3), p.321-330
19.
Genetic and biochemical characterization of hyicin 3682, the first bacteriocin reported for Staphylococcus hyicus
by Carlin Fagundes, Patrícia
Microbiological research, 2017, Vol.198, p.36-46
20.
Epidermin and gallidermin: Staphylococcal lantibiotics
by Götz, Friedrich
International journal of medical microbiology, 2013, Vol.304 (1), p.63-71
